Australia, Jan. 28 -- Absci Corp., owns the trademark (2579034) for 'ABSCI' till Aug. 20, 2035.

Status: registered: Registered/protected

Classes: 1 [Biological preparations for medical research purposes], 5 [Cells for medical or clinical use; antibodies for the treatment of inflammatory and fibrotic diseases], 40 [Biotechnological services, namely, custom production and purification of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services, namely, custom production of cell lines to produce proteins, such as hormones, cytokines, antibodies and antibody fragments.], 42 [Scientific and technological consulting services relating to producing, assaying, and purifying biotechnological products; research and development in the pharmaceutical and biotechnology fields; services of biotechnical and pharmacological laboratories, namely, scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations; scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations, and scientific consultation related thereto; scientific research, namely, carrying out feasibility studies relating to the production of biotechnological products for use in preparing pharmaceutical preparations; discovery of pharmaceutical preparations, medicines and medicaments; technological services, namely, technological consultation relating to the production of biotechnological products for use in preparing pharmaceutical preparations; Bioinformatics research services, namely, analyzing complex biological data through the use of artificial intelligence, and testing and evaluation of biologics through artificial intelligence; computer assisted biologics design involving the use of artificial intelligence technology; Biotechnological services, namely, discovery of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services, namely, discovery of cell lines to produce proteins, such as hormones, cytokines, antibodies and antibody fragments.] and 5 [biological preparations for medical research purposes;cells for medical or clinical use;antibodies for the treatment of inflammatory and fibrotic diseases]

Type of Mark: Word

Date of Acceptance: Nov. 17, 2025

Registration Advertised: Jan. 27

For further details contact PHILLIPS ORMONDE FITZPATRICK.

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2579034.

Disclaimer: Curated by HT Syndication.